About Sector focus Responsible Investing Portfolio Team Investors News Contact Login A LEADING PRIVATE EQUITY FIRM INVESTING IN EUROPE Manufacturer and distributor of generic pharmaceuticals We invest in Western European mid-market companies At Duke Street Private Equity, we have been investing in mature, mid-market Western European businesses for over twenty years. Our investment strategy is concentrated on four sectors: Consumer, Healthcare, Industrials & Engineering and Services. Typically we invest in companies with an enterprise value of between £50m - £350m. Our strategy is based on our ability to identify unique opportunities and add value to each business we acquire. We aim to transform the prospects of the companies that we invest in. Origination beyond the obvious We focus our efforts on transactions developed on an exclusive basis. We actively seek complex deals which other investors may avoid if we think they have underlying growth potential. Value creation Our mission is to accelerate the growth of the companies that we buy. We help our companies grow both organically and through acquisition. Supportive Structure We have developed a robust approach to building relationships between ourselves, the CEOs of our portfolio businesses and our Operating Partners. Sector focus We believe sector knowledge is critical, which is why we have dedicated teams focusing on our four core sectors. This, alongside the deep industry experience of our Operating Partners, has allowed us to create a proven track record of successfully building companies. CONSUMER HEALTHCARE INDUSTRIALS & ENGINEERING SERVICES Responsible Investing ESG Considerations At Duke Street we consider environmental, social and governance (ESG) issues throughout the investment decision-making process and life-cycle. We believe that robust and well-implemented ESG policies and practices contribute directly to the long-term success and sustainability of our portfolio companies. Implemented effectively, they help us to protect and enhance reputation and financial performance whilst creating stronger, more valuable companies which can create benefits for all stakeholders: from employees to customers, suppliers to shareholders, and the wider community at large. We review our approach to ESG regularly to ensure that it continues to reflect best practice. As part of our commitment to actively address climate risks, Duke Street is a signatory to the Initiative Climate International (iCI), a global private equity initiative focused on cross-sector collaboration to develop pragmatic solutions to address climate change and, in particular, reduce carbon emissions of portfolio companies. iCI is endorsed by the UN-sponsored Principles for Responsible Investment (PRI). ENVIRONMENTAL GOVERNANCE SOCIAL SUSTAINABILITY Find out how Duke Street portfolio companies make responsible investing a reality. Latest News Our Portfolio Grid view All Consumer Healthcare Industrials & Engineering Services Realised Unrealised Previous Next Our Team Grid view Investment team Operating partners All Previous CHARLIE TROUP MANAGING PARTNER Phone Linkedin STUART MCMINNIES MANAGING PARTNER Phone Linkedin JAMES ALMOND PARTNER Phone Linkedin JASON LAWFORD PARTNER Phone Linkedin PAUL ADAMS PARTNER Phone Linkedin Next Investors The Duke Street investor base comprises traditional funds and pools of committed capital alongside co-investment mandates from high quality investors, which include Fund of Funds, Pension Funds, Insurance Companies and Family Offices amongst others. Our investors are long-term supporters of the private equity model and are located across the globe with substantial support from North America and Europe. Duke Street has invested over €2.5bn in more than 50 companies over the last 25 years and has achieved strong returns in excess of 20% IRR throughout the cycle. Duke Street adopted a deal-by-deal funding strategy in 2012, subsequently raising committed capital to invest alongside its co-investment mandates. Duke Street itself invests substantially in each deal ensuring maximum alignment between Duke Street, its investors and management teams. Investors by type Investors by region Funds Of Funds - 41% Financial Institutions - 29% Pension Funds - 18% Family Offices - 12% Latest News All ESG Previous 28 JUN 2021 Kent Pharmaceuticals and Athlone Laboratories acquires Dalkeith Group Duke Street is pleased to announce that its portfolio company, Kent Pharmaceuticals and Athlone Laboratories, manufacturers and distributors of specialist off-patent/generic pharmaceuticals, has agreed to acquire Dalkeith Group, the UK-based distributor of generic pharmaceutical and over-the-counter (OTC) products to wholesale, pharmacy and supermarket channels. See more Share on LinkedIn Share Next Contact Map Satellite Keyboard shortcuts Map data ©2021 Terms of Use Report a map error Duke Street Nations House, 103 Wigmore Street, London W1U 1QS Tel: +44 (0)20 7663 8500 Fax: +44 (0)20 7663 8501 Email us mail@dukestreet.com You can use the email address above, or write to us for additional security. Enquiries will of course be treated in strictest confidence from time of receipt but we cannot guarantee the security of email (or other) communications with us. Disclaimer / Cookies / Privacy Notice Duke Street LLP, Duke Street General Partner Limited and Duke Street V Limited are authorised and regulated by the Financial Conduct Authority. © Copyright Duke Street 2021 Site design: designwildwest.com Back to the top